These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 77732)
21. Modification of the second set reaction by antilymphocytic serum. Boak JL; Draper V; House AK; Pattisson PH Br J Surg; 1971 Apr; 58(4):300-1. PubMed ID: 4396709 [No Abstract] [Full Text] [Related]
22. [Suppression of humoral antibody formation in rabbits. Administration of alpha globulin fraction of human plasma and antilymphocytic globulin (author's transl)]. Bednaăík T; Cajthamlová H Cas Lek Cesk; 1976 Dec; 115(48):1490-2. PubMed ID: 63333 [No Abstract] [Full Text] [Related]
23. The effect of splenectomy on graft-versus-host disease (GVHD) in mice. Glucksberg H; Fefer A J Reticuloendothel Soc; 1972 Nov; 12(5):537-44. PubMed ID: 4120362 [No Abstract] [Full Text] [Related]
24. [Immunopharmacological actions of neurotropin. (2). Effect of neurotropin on graft-versus-host reaction (author's transl)]. Yanagihara Y; Shida T; Yoshii H Nihon Yakurigaku Zasshi; 1981 Nov; 78(5):451-8. PubMed ID: 7327459 [TBL] [Abstract][Full Text] [Related]
25. Use of sponge matrix allografts for concurrent monitoring of immunologic and pharmacologic events at a graft site. Sirinek LP; Zinn NE; Ferguson RM; Orosz CG Transplantation; 1987 Jul; 44(1):161-4. PubMed ID: 3603678 [No Abstract] [Full Text] [Related]
26. [Effect of phytohemagglutinin and antilymphocyte serum on the survival time of homologous skin grafts in mice]. Kaden J; Kaden K Z Exp Chir; 1973; 6(6):401-9. PubMed ID: 4152194 [No Abstract] [Full Text] [Related]
27. Prevention of graft-versus-host disease by Fab fragments derived from ALG. Richie ER; Gallagher MT; Trentin JJ Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467 [No Abstract] [Full Text] [Related]
28. Influence of the alpha-globulin fraction isolated from calf serum on graft-versus-host reaction in strongly histoincompatible mice. Skopińska E; Krzywicka E; Wichrzycka E; Zaleska-Rutczyńska Z Arch Immunol Ther Exp (Warsz); 1976; 24(3):383-9. PubMed ID: 60985 [TBL] [Abstract][Full Text] [Related]
29. [Histological studies on graft versus host reaction in the mouse after treating the donor animal with antilymphocyte serum]. Beil E; Becker G; Thierfelder S; Mempel W; Rodriguez E Verh Dtsch Ges Pathol; 1970; 54():191-7. PubMed ID: 4104529 [No Abstract] [Full Text] [Related]
30. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Wood ML; Monaco AP; Gozzo JJ; Liegeois A Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508 [No Abstract] [Full Text] [Related]
31. Reduction of GvH splenomegaly in mice by antilymphocyte serum (ALS): correlation of the effect with immunosuppressive potency of ALS. Mazuran R; Volić B; Silobrcić V Z Immunitatsforsch Exp Klin Immunol; 1974 Sep; 147(4):378-83. PubMed ID: 4157053 [No Abstract] [Full Text] [Related]
32. Inhibitory effect of alpha-globulin on the second set allograft reaction. Glaser M; Nelken D Proc Soc Exp Biol Med; 1972 Jul; 140(3):996-8. PubMed ID: 4114255 [No Abstract] [Full Text] [Related]
33. Synergistic effect of antilymphocyte serum and the graft-versus-host reaction on murine skin allograft survival. Lapp WS Transplantation; 1973 May; 15(5):469-73. PubMed ID: 4145550 [No Abstract] [Full Text] [Related]
34. Bone marrow transplantation in DLA-haploidentical canine littermates: fractionated total body irradiation (FTBI) and in vitro treatment of the marrow graft with anti-T-cell globulin (ATCG). Kolb HJ; Bodenberger U; Rodt HV; Rieder I; Netzel B; Grosse-Wilde H; Scholz S; Thierfelder S Haematol Blood Transfus; 1980; 25():61-71. PubMed ID: 7021361 [No Abstract] [Full Text] [Related]
35. [Role of antithymocyte globulin in reducing the incidence of complications after allogeneic hemopoietic cell transplantation]. Zalialov IuR; Ganapiev AA; Golubovskaia IK; Afanas'ev BV Ter Arkh; 2010; 82(8):53-6. PubMed ID: 20873247 [TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy for clinically established graft-versus-host disease in mice. Glucksberg H; Fefer A Cancer Res; 1973 Apr; 33(4):859-61. PubMed ID: 4144500 [No Abstract] [Full Text] [Related]
37. [Synergism of conditioning and immunosuppressive treatment in the test model of the graft-versus-host-reaction (author's transl)]. Meyer U; Hoppe I; Jahn E Z Immunitatsforsch Exp Klin Immunol; 1974 Feb; 146(4):334-45. PubMed ID: 4157052 [No Abstract] [Full Text] [Related]
38. [Use of monoclonal antibodies for the prevention of graft-versus-host and host-versus-graft reaction in allogenic bone marrow grafts]. Hervé P Nephrologie; 1987; 8(3):103-8. PubMed ID: 3309699 [TBL] [Abstract][Full Text] [Related]
39. Prostaglandins and cell-mediated immunity. The role of prostaglandin E1 in the induction of host-versus-graft and graft-versus-host reactions in mice. Mertin J; Stackpoole A; Shumway SJ Transplantation; 1984 Apr; 37(4):396-402. PubMed ID: 6710595 [TBL] [Abstract][Full Text] [Related]
40. Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum. Floersheim GL; Brune K Transplant Proc; 1971 Mar; 3(1):688-92. PubMed ID: 4398510 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]